LIVN - LivaNova PLCAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $79.60 | Open | $80.60 |
| Volume | 697.9K | Market Cap | 3.874B |
| Yield | Last Dividend |
| Innovative Report on Artificial Heart Lu... | 03/04/21 |
| Global Artificial Heart Lung Machines Market Synopsis: The report covers a forecast and an analysis of the Artificial Heart Lung Machines Market on a ... | |
| Permira bids for $3.7bn medical device m... | 03/03/21 |
| Buyout group made offer last month and talks are ongoing, people familiar with matter say | |
| LivaNova Reports Fourth Quarter and Full... | 02/24/21 |
| LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC today reported results for the quarter and full-year ended December 31, 2020. | |
| Earnings Scheduled For February 24, 2021 | 02/24/21 |
| Companies Reporting Before The Bell ??? Pinnacle West Capital (NYSE: PNW ) is expected to report quarterly earnings at $0.04 per share on revenue of $... | |
| Prosthetic Heart Valve Market Statistics... | 02/01/21 |
| Global Prosthetic Heart Valve Market to Grow Rapidly due to Increasing Application in Healthcare Sector Over the projected period, the growing prevale... | |
| Medical Implant Market Outlook 2021 - 20... | 01/29/21 |
| According to the report, the medical implants industry garnered $85.38 billion in 2019, and is projected to generate $147.46 billion by 2027, witnessi... | |
| Medical Implant Market 2021: Size, Share... | 01/25/21 |
| According to the report published by Allied Market Research, The medical implants market accounted for $85.38 billion in 2019, and is expected to reac... | |
| Congestive Heart Failure Treatment Devic... | 01/13/21 |
| ReportsnReports.com the exclusive leading provider of market research reports published research report on ???Global Congestive Heart Failure (CHF) Tr... | |
| Noctrix Health, Inc. Completes $17M Mill... | 01/11/21 |
| SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ -- Noctrix Health, Inc., a private medical device company, today announced it has completed a Series B finan... | |
| Neurostimulation Devices Market 2020 Glo... | 12/14/20 |
| Market Scenario: Neurostimulation is a modulation of the nervous system???s activity. It is deliberately carried out by using invasive and non-invasiv... | |
| LivaNova Announces Board Appointment and... | 12/07/20 |
| LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC today announced a series of enhancements to the Company???s governance. | |
| LivaNova to Host Satellite Symposium on ... | 12/04/20 |
| LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova announced it will host ???Updates and Advances in Neuromodulation,??? a satellite symposium at AES2020 on ... | |
| LivaNova to Present at the Berenberg Eur... | 11/25/20 |
| LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced CEO Damien McDonald will participate in discussions at the Berenberg European Conference 202... | |
| Implantable Cardioverter Defibrillator M... | 11/24/20 |
| An implantable cardioverter-defibrillator (ICD) is a medical device, it is a small battery-powered apparatus located in the chest to monitor heart rhy... | |
| LivaNova to Participate in the Piper San... | 11/23/20 |
| LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova announced CEO Damien McDonald will participate in discussions at the Piper Sandler 32nd Annual Virtual Hea... | |
| LivaNova to Present at the Stifel 2020 V... | 11/10/20 |
| LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova today announced Damien McDonald, CEO, will present at the Stifel 2020 Virtual Healthcare Conference on Tue... | |
| Heart Valve Market Is Thriving Worldwide... | 11/06/20 |
| New Study On Heart Valve Market: According to the ???Market Growth Insight???, the Heart Valve market is anticipated to be estimated at USD XX billion... | |
| LivaNova Does Earnings Surprise History ... | 10/29/20 |
| LivaNova announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| LivaNova Reports Third Quarter 2020 Resu... | 10/29/20 |
| LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for... | |
| Earnings Scheduled For October 29, 2020 | 10/29/20 |
| Companies Reporting Before The Bell ??? PG&E (NYSE: PCG ) is likely to report quarterly earnings at $0.27 per share on revenue of $4.72 billion. ??? S... | |
| Autotransfusion Device Market New Busine... | 10/28/20 |
| The autotransfusion device market by product is segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual... | |
| Perfusion Systems Market Demand Analysis... | 10/23/20 |
| The perfusion systems market accounted to US$ 1,044.75 Mn in 2018 and is expected to grow at a CAGR of 3.8% during the forecast period 2019 - 2027, to... | |
| LivaNova (NASDAQ:LIVN) Given New $65.00 ... | 10/22/20 |
| LivaNova (NASDAQ:LIVN) had its price target increased by Robert W. Baird from $55.00 to $65.00 in a research note released on Wednesday morning, The F... | |
| Highly Trending Report on Electroceutica... | 10/22/20 |
| Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Electroceuticals Bioelectric Medicine Market which would ment... | |
| LivaNova (LIVN) Scheduled to Post Quarte... | 10/21/20 |
| LivaNova (NASDAQ:LIVN) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, October 29th. Analysts expect Li... | |
| MORGAN STANLEY: Buy these 61 stocks that... | 10/21/20 |
| Summary List Placement When it comes to his outlook on the market for the next few months, Morgan Stanley's Mike Wilson is pessimistic. The bank's chi... | |
| Spinal Cord Stimulators Market 2020 Glob... | 10/21/20 |
| A complete discussion about numerous market related topics in this Spinal Cord Stimulators Market research report is sure to aid the client in studyin... | |
| LivaNova (NASDAQ:LIVN) Price Target Rais... | 10/21/20 |
| LivaNova (NASDAQ:LIVN) had its price objective upped by research analysts at Robert W. Baird from $55.00 to $65.00 in a report issued on Wednesday, Th... | |
| LivaNova (NASDAQ:LIVN) Lifted to Hold at... | 10/20/20 |
| BidaskClub upgraded shares of LivaNova (NASDAQ:LIVN) from a sell rating to a hold rating in a research report released on Saturday morning, BidAskClub... | |
| Stem Cell Repair Market 2020-2028 advanc... | 10/14/20 |
| A special process helps isolate the needed cells by using a centrifuge. Those cells are then delivered to the area of injury such as an arthritic knee... | |
| Hold rating | 03/03/21 |
| Berenberg downgrades from Buy to Hold rating and announces Price Target of $84.00 | |
| Date | 2021-02-24 (BMO) | Est. (EPS/Rev.) | $0.66/ 268.83M |
| Actual (EPS/Rev.) | $0.71/ $269.60 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
